Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoshio Fujitani

Showing results (31-40 of 139) with videos related to

Pageof 14
Sort By:
Endocrine Journal|May 29, 2008
Combined expression of transcription factors induces AR42J-B13 cells to differentiate into insulin-producing cellsTakeshi Ogihara, Yoshio Fujitani, Toyoyoshi Uchida, et al.
Plos One|August 17, 2022
Establishment of an enzyme-linked immunosorbent assay for mouse pancreatic polypeptide clarifies the regulatory mechanism of its secretion from pancreatic γ cellsDaisuke Saito, Yuko Nakagawa, Takashi Sato, et al.
Diabetes Research and Clinical Practice|April 24, 2007
Role of PDX-1 and MafA as a potential therapeutic target for diabetesHideaki Kaneto, Takeshi Miyatsuka, Yoshio Fujitani, et al.
The Journal of Biological Chemistry|January 9, 2023
Overexpression of Pdx1, reduction of p53, or deletion of CHOP attenuates pancreas hypoplasia in mice with pancreas-specific O-GlcNAc transferase deletionAlicia Wong, Samantha Pritchard, Mackenzie Moore, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 5, 2008
Carbonic anhydrase II-positive pancreatic cells are progenitors for both endocrine and exocrine pancreas after birthAkari Inada, Cameron Nienaber, Hitoshi Katsuta, et al.
Developmental Biology|September 12, 2006
Complementation rescue of Pdx1 null phenotype demonstrates distinct roles of proximal and distal cis-regulatory sequences in pancreatic and duodenal expressionDaniel F Boyer, Yoshio Fujitani, Maureen Gannon, et al.
Endocrine Journal|September 27, 2007
Calcium channel blocker, azelnidipine, reduces lipid hydroperoxides in patients with type 2 diabetes independent of blood pressureChie Ohmura, Hirotaka Watada, Tomoaki Shimizu, et al.
Scientific Reports|December 10, 2022
STAT3 suppression and β-cell ablation enhance α-to-β reprogramming mediated by Pdx1Yuka Wakabayashi, Takeshi Miyatsuka, Masaki Miura, et al.
Endocrine Journal|December 23, 2006
Long-term effect of combination therapy with mitiglinide and once daily insulin glargine in patients who were successfully switched from intensive insulin therapy in short-term studyNaoki Kumashiro, Tomoaki Yoshihara, Yoshie Kanazawa, et al.
Endocrine Journal|July 17, 2020
Rubicon in pancreatic beta cells plays a limited role in maintaining glucose homeostasis following increased insulin resistanceShuhei Aoyama, Yuya Nishida, Yoshio Fujitani, et al.
Pageof 14

Showing results (31-40 of 139) with videos related to

Sort By:
Pageof 14
Endocrine Journal|May 29, 2008
Combined expression of transcription factors induces AR42J-B13 cells to differentiate into insulin-producing cellsTakeshi Ogihara, Yoshio Fujitani, Toyoyoshi Uchida, et al.
Plos One|August 17, 2022
Establishment of an enzyme-linked immunosorbent assay for mouse pancreatic polypeptide clarifies the regulatory mechanism of its secretion from pancreatic γ cellsDaisuke Saito, Yuko Nakagawa, Takashi Sato, et al.
Diabetes Research and Clinical Practice|April 24, 2007
Role of PDX-1 and MafA as a potential therapeutic target for diabetesHideaki Kaneto, Takeshi Miyatsuka, Yoshio Fujitani, et al.
The Journal of Biological Chemistry|January 9, 2023
Overexpression of Pdx1, reduction of p53, or deletion of CHOP attenuates pancreas hypoplasia in mice with pancreas-specific O-GlcNAc transferase deletionAlicia Wong, Samantha Pritchard, Mackenzie Moore, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 5, 2008
Carbonic anhydrase II-positive pancreatic cells are progenitors for both endocrine and exocrine pancreas after birthAkari Inada, Cameron Nienaber, Hitoshi Katsuta, et al.
Developmental Biology|September 12, 2006
Complementation rescue of Pdx1 null phenotype demonstrates distinct roles of proximal and distal cis-regulatory sequences in pancreatic and duodenal expressionDaniel F Boyer, Yoshio Fujitani, Maureen Gannon, et al.
Endocrine Journal|September 27, 2007
Calcium channel blocker, azelnidipine, reduces lipid hydroperoxides in patients with type 2 diabetes independent of blood pressureChie Ohmura, Hirotaka Watada, Tomoaki Shimizu, et al.
Scientific Reports|December 10, 2022
STAT3 suppression and β-cell ablation enhance α-to-β reprogramming mediated by Pdx1Yuka Wakabayashi, Takeshi Miyatsuka, Masaki Miura, et al.
Endocrine Journal|December 23, 2006
Long-term effect of combination therapy with mitiglinide and once daily insulin glargine in patients who were successfully switched from intensive insulin therapy in short-term studyNaoki Kumashiro, Tomoaki Yoshihara, Yoshie Kanazawa, et al.
Endocrine Journal|July 17, 2020
Rubicon in pancreatic beta cells plays a limited role in maintaining glucose homeostasis following increased insulin resistanceShuhei Aoyama, Yuya Nishida, Yoshio Fujitani, et al.
Pageof 14